Complex genetic and epigenetic modifications underlie the initiation and progression of cancer. Scientists are attempting to unravel the epigenome to gain an understanding of the interplay between oncogenesis and epigenetics. To explore these issues, The Scientist has assembled a panel of experts to discuss the importance of epigenetic profiling in cancer research, and to explore how this knowledge can be applied to develop targeted therapies. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics related to their research.

Topics to be covered include:

  • The role of epigenetic dysregulation of long, non-coding RNAs (lncRNAs) in tumorigenesis
  • Epigenetic engineering as a means for studying aberrant or deleterious modifications

Meet the Speakers:

Dr. Ahmad M. Khalil
Assistant Professor of Genetics and Genome Sciences
Kavli Fellow (2014-Present)
Case Western Reserve University School of Medicine

Dr. Lanlan Shen
Associate Professor
Baylor College of Medicine

Sponsored by

Swift Biosciences


Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!